Medical

The rapid global spread of the novel coronavirus COVID-19 affects every industry on the planet, legal cannabis included.

Early reports indicate dispensaries and adult-use cannabis stores on the West Coast are seeing a mix of sales bumps, or sales slumps, depending on the level of local infection.

Seattle bump, then slump

The CDC recommends everyone have at least one month’s supply of medication on hand—in the likely event supplies are strained, or local stay-at-home orders of 14 or 28 days are issued.

For many folks, cannabis is their medication.

An amendment that establishes a potency cap of 10% THC for medical marijuana patients under 21 has made its way back to the Florida House floor, where it was tacked onto a larger healthcare bill during a floor session Thursday.

The amendment, which passed with a voice vote on the floor, would not apply to patients 21 and younger with terminal illnesses.

In this article Global Market Insights discusses the impact of the medical cannabis market on the US healthcare industry.

Since the introduction of medical cannabis in America, the cannabis market has had an unprecedented impact on the US healthcare industry. Medical cannabis refers to the use of the cannabis sativa or cannabis indica plant, or its extracts, to relieve the symptoms of or treat various diseases and health conditions.

Medical cannabis patients in the UK will now have faster access to their prescriptions thanks to new changes on import restrictions.

The UK government has now approved changes to import restrictions to ensure that people with prescriptions for cannabis-based products for medical use do not have their treatment delayed or interrupted.

Utah Gov. Gary Herbert signed the Medical Cannabis Amendments bill Friday after the bill unanimously passed in the House on Thursday.

With some 40 amendments, the enrolling of SB121 comes just a few days before the program opens for the first day of business on Monday.

In a last-ditch effort at the tail end of the legislative session, the chamber most likely to oppose a cap on THC has taken up the issue.

After weeks of rumors that the Florida House was pushing an amendment that would put a cap on the amount of THC in all medical marijuana at 10% potency, the proposal was finally filed Friday afternoon in the Senate.

THC is the main psychoactive compound in marijuana, and can come in the form of whole-flower marijuana, tinctures, oils, vaporizers and edibles.

Legal cannabis isn’t new to Canada—in fact it’s been available to patients with qualifying medical conditions since 2001. There’s no doubt that when cannabis became legal to all adults in 2018, it was made possible in large part by the persistence and advocacy of patients.

Veterans are pushing back against a proposal backed by Florida House leaders that would limit the amount of THC in medical marijuana, an effort they say is not based on science and could be harmful to veterans with post-traumatic stress disorder.

House Speaker José Oliva has called the proposed 10% cap on THC, the euphoria-inducing component in cannabis, a priority, but Senate leaders have remained skeptical about the need for such a limit.

Smokable cannabis now being sold by the state’s medical marijuana treatment centers has potency of as high as 30%.

State lawmakers took steps on two bills Thursday that could bring protections for companies that insure cannabis-related companies in the Garden State and also allow those on workers’ compensation to have their medical weed covered.

The state Assembly committee on financial institutions advanced the two bills, but the state Senate has yet to take up either.

A Kentucky House committee voted today to add Kentucky to the list of at least 33 other states with a government-regulated medicinal marijuana program.

The program would be established under House Bill 136, sponsored by Rep. Jason Nemes, R-Louisville, and Rep. John Sims Jr., D-Flemingsburg, approved today by the House Judiciary Committee. The bill sets out policies for cultivation, processing, sale, distribution and use of medicinal marijuana, should HB 136 become law.